SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-012637
Filing Date
2023-08-01
Accepted
2023-08-01 08:01:20
Documents
87
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q hrmy-20230630x10q.htm   iXBRL 10-Q 1567026
2 EX-31.1 hrmy-20230630xex31d1.htm EX-31.1 16275
3 EX-31.2 hrmy-20230630xex31d2.htm EX-31.2 16843
4 EX-32.1 hrmy-20230630xex32d1.htm EX-32.1 9975
5 EX-32.2 hrmy-20230630xex32d2.htm EX-32.2 9467
  Complete submission text file 0001558370-23-012637.txt   7799798

Data Files

Seq Description Document Type Size
6 EX-101.SCH hrmy-20230630.xsd EX-101.SCH 59211
7 EX-101.CAL hrmy-20230630_cal.xml EX-101.CAL 76432
8 EX-101.DEF hrmy-20230630_def.xml EX-101.DEF 166122
9 EX-101.LAB hrmy-20230630_lab.xml EX-101.LAB 487641
10 EX-101.PRE hrmy-20230630_pre.xml EX-101.PRE 358982
81 EXTRACTED XBRL INSTANCE DOCUMENT hrmy-20230630x10q_htm.xml XML 1448278
Mailing Address 630 W GERMANTOWN PIKE SUITE 215 PLYMOUTH MEETING PA 19462
Business Address 630 W GERMANTOWN PIKE SUITE 215 PLYMOUTH MEETING PA 19462 (484) 539-9800
Harmony Biosciences Holdings, Inc. (Filer) CIK: 0001802665 (see all company filings)

IRS No.: 822279923 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39450 | Film No.: 231129709
SIC: 2834 Pharmaceutical Preparations